JACOBS LEVY EQUITY MANAGEMENT, INC - SUTRO BIOPHARMA INC ownership

SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 116 filers reported holding SUTRO BIOPHARMA INC in Q2 2022. The put-call ratio across all filers is 2.02 and the average weighting 0.1%.

Quarter-by-quarter ownership
JACOBS LEVY EQUITY MANAGEMENT, INC ownership history of SUTRO BIOPHARMA INC
ValueSharesWeighting
Q3 2023$1,477,148
-44.4%
425,691
-25.5%
0.01%
-40.0%
Q2 2023$2,656,977
-13.5%
571,393
-14.0%
0.02%
-21.1%
Q1 2023$3,070,457
-43.1%
664,601
-0.4%
0.02%
-47.2%
Q4 2022$5,393,207
+30.7%
667,476
-10.2%
0.04%
+9.1%
Q3 2022$4,125,000
-22.2%
743,228
-26.9%
0.03%
-19.5%
Q2 2022$5,299,000
+3.9%
1,017,034
+63.9%
0.04%
+20.6%
Q1 2022$5,100,000
+110.2%
620,480
+482.2%
0.03%
+78.9%
Q1 2021$2,426,000
-29.0%
106,581
-32.2%
0.02%
-36.7%
Q4 2020$3,415,000
+540.7%
157,301
+196.7%
0.03%
+400.0%
Q3 2020$533,000
+9.4%
53,013
-15.5%
0.01%
+20.0%
Q2 2020$487,000
-27.1%
62,727
-4.3%
0.01%
-44.4%
Q1 2020$668,000
-7.1%
65,531
+0.3%
0.01%
+28.6%
Q4 2019$719,000
+156.8%
65,334
+112.2%
0.01%
+133.3%
Q3 2019$280,000
-43.3%
30,786
-29.0%
0.00%
-57.1%
Q2 2019$494,000
-0.4%
43,367
-0.4%
0.01%0.0%
Q1 2019$496,00043,5260.01%
Other shareholders
SUTRO BIOPHARMA INC shareholders Q2 2022
NameSharesValueWeighting ↓
SV Health Investors, LLC 1,824,542$39,611,00019.08%
Samsara BioCapital, LLC 1,675,579$36,377,0003.66%
SILVERARC CAPITAL MANAGEMENT, LLC 185,000$4,016,0002.33%
Affinity Asset Advisors, LLC 200,000$4,342,0002.30%
Altium Capital Management LP 276,719$6,008,0002.24%
FRAZIER MANAGEMENT LLC 1,001,421$21,741,0001.67%
BVF INC/IL 1,854,162$40,254,0001.58%
Asymmetry Capital Management, L.P. 157,583$3,421,0001.56%
Parkman Healthcare Partners LLC 266,645$5,789,0001.48%
AJU IB Investment Co., Ltd. 175,000$3,799,0001.44%
View complete list of SUTRO BIOPHARMA INC shareholders